Meenakshi Steel Industries Ltd
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE 6.47 %
- ROE 0.94 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.96% over past five years.
- Company has a low return on equity of 0.42% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Products Iron & Steel Products
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.65 | 0.07 | 0.03 | 0.02 | 0.04 | 0.57 | 14.08 | 20.17 | 24.85 | 22.44 | 18.47 | 18.81 | |
| 0.03 | 0.04 | 0.07 | 0.08 | 0.08 | 4.47 | 0.52 | 0.20 | 3.69 | 3.34 | 2.25 | 0.48 | |
| Operating Profit | 0.62 | 0.03 | -0.04 | -0.06 | -0.04 | -3.90 | 13.56 | 19.97 | 21.16 | 19.10 | 16.22 | 18.33 |
| OPM % | 95.38% | 42.86% | -133.33% | -300.00% | -100.00% | -684.21% | 96.31% | 99.01% | 85.15% | 85.12% | 87.82% | 97.45% |
| 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.25 | 0.22 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.41 | 14.26 | 19.61 | 19.45 | 15.37 | 16.66 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.62 | 0.04 | -0.04 | -0.06 | -0.04 | -3.90 | 6.15 | 5.71 | 1.61 | -0.35 | 1.10 | 1.89 |
| Tax % | 12.90% | 50.00% | 0.00% | -16.67% | 25.00% | 428.21% | 27.64% | 25.39% | 313.04% | 2.86% | 23.64% | 27.51% |
| 0.54 | 0.03 | -0.04 | -0.05 | -0.05 | -20.60 | 4.45 | 4.26 | -3.42 | -0.36 | 0.84 | 1.37 | |
| EPS in Rs | ||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 75% |
| 5 Years: | 6% |
| 3 Years: | -9% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 47% |
| 5 Years: | -21% |
| 3 Years: | 34% |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 |
| Reserves | 7.65 | 7.68 | 7.63 | 7.59 | 277.26 | 133.60 | 148.16 | 148.43 | 145.61 | 144.14 | 145.21 | 142.80 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 123.00 | 170.00 | 155.00 | 186.00 | 106.00 | 175.00 | |
| 0.01 | 0.00 | 0.02 | 0.01 | 0.00 | 16.81 | 21.44 | 0.98 | 0.94 | 1.07 | 0.42 | 0.61 | |
| Total Liabilities | 9.65 | 9.67 | 9.64 | 9.59 | 279.25 | 152.40 | 294.59 | 321.40 | 303.54 | 333.20 | 253.62 | 320.40 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 5.08 | 8.43 | 9.11 | 9.55 | 278.78 | 80.55 | 105.02 | 101.03 | 101.63 | 95.53 | 89.86 | 94.29 |
| 4.57 | 1.24 | 0.53 | 0.04 | 0.47 | 71.85 | 189.57 | 220.37 | 201.91 | 237.67 | 163.76 | 226.11 | |
| Total Assets | 9.65 | 9.67 | 9.64 | 9.59 | 279.25 | 152.40 | 294.59 | 321.40 | 303.54 | 333.20 | 253.62 | 320.40 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | -0.08 | -77.12 | -110.06 | -26.61 | -4.68 | -0.40 | 0.12 | 1.30 | ||||
| 0.00 | 0.07 | 79.58 | -13.98 | -21.28 | 27.48 | -38.79 | 82.66 | -65.56 | ||||
| 0.00 | 0.00 | 0.00 | 123.00 | 47.00 | -15.00 | 31.00 | -80.00 | 69.00 | ||||
| Net Cash Flow | 0.00 | -0.01 | 2.46 | -1.04 | -0.89 | 7.79 | -8.19 | 2.78 | 4.75 | |||
| Free Cash Flow | 0.00 | -0.08 | -77.12 | -110.06 | -26.61 | -4.68 | -0.40 | 0.12 | 1.30 | |||
| CFO/OP | 0% | 200% | 1,975% | -669% | 4% | -14% | 7% | 12% | 17% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | 2,555.00 | 0.00 | 6,083.33 | -182.50 | 4,288.75 | 33,663.25 | -231.50 | 396.67 | 16.01 | 17.89 | 24.90 | 16.11 |
| ROCE % | 6.62% | 0.41% | -0.41% | -0.62% | -0.03% | -1.88% | 6.64% | 6.73% | 6.81% | 6.02% | 5.63% | 6.47% |
Insights
In beta| Mar 2012 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Number of Manufacturing Sites Number |
|
||||
| Cumulative Patents Filed Number |
|||||
| Number of Permanent Employees Number |
|||||
| R&D Spend as Percentage of Turnover % |
|||||
| Specific Energy Consumption Reduction % |
|||||
| Global Ranking in Vitamin B3 (Niacinamide/Niacin) Rank |
|||||
| Number of Active Molecules/Products in Portfolio Number |
|||||
| Number of Dedicated R&D Scientists Number |
|||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
28 May - We submit herewith Newspaper cutting where Audited Financial Results duly approved at the Board Meeting held on 27.05.2026 is published
-
Board Meeting Outcome for Audited Financial Results (Standalone And Consolidated) For 4Th Quarter And Year Ended 31.03.2026
27 May - Board approved audited standalone and consolidated FY26 results on 27 May 2026; auditors issued unmodified opinion.
-
Audited Financial Results For The 4Th Quarter And Year Ended 31St March, 2026
27 May - Board approved audited Q4 and FY2026 standalone and consolidated results; auditors issued unmodified opinion.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
26 May - Annual Secretarial Compliance Report for FY ended 31 March 2026; no non-compliance observed.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
18 May - We submit herewith newspaper cutting of the newspaper wherein Notice convening the Board Meeting scheduled to be held on 27.05.2026, is attached herewith.